tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Vivimed Labs’ Debt Assigned to Rare Asset Reconstruction Ltd.

Story Highlights
Vivimed Labs’ Debt Assigned to Rare Asset Reconstruction Ltd.

Meet Your ETF AI Analyst

Vivimed Labs Limited ( (IN:VIVIMEDLAB) ) has provided an announcement.

Vivimed Labs Limited has announced that Rare Asset Reconstruction Ltd. has acquired the company’s financial assets from the State Bank of India. This transfer includes all underlying security interests, rights, and obligations, allowing Rare ARC to recover dues from Vivimed Labs, impacting the company’s financial restructuring and stakeholder obligations.

More about Vivimed Labs Limited

Vivimed Labs Limited operates in the pharmaceutical industry, focusing on the development and production of specialty chemicals and pharmaceutical products. The company is known for its diverse range of healthcare and personal care products, catering to both domestic and international markets.

Current Market Cap: 406.3M INR

Find detailed analytics on VIVIMEDLAB stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1